Advertisement

Editor’s introduction

Measles and poliomyelitis: vaccines, immunization, and control
  • Edouard Kurstak

Abstract

Measles and poliomyelitis happen to be two well known viral diseases which inconceivably remain yet to be fully eradicated worldwide. Similarities exist in their both, being preventable with highly effective and safe vaccines, and in causing acute seif limiting infections exclusively in humans. Despite their successful control in the industrialized countries of the world, their threat as two major diseases of the developing world still remains. Immuni-zation programmes proved to be perhaps more a successful experience with poliomyelitis than measles in Controlling and eliminating infection.

Keywords

Measle Virus Immunization Coverage Measle Vaccine Oral Poliovirus Vaccine Measle Vaccination 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Henderson RH ,Keja J, Hayden G (1988) Immunizing the children of the world: Progress and prospects. Bull WHO 66: 535–543PubMedGoogle Scholar
  2. 2.
    Clements CJ, Strassburg M, Cutts FT, Milstein J, Torel C (1992) Global control of measles. In: Kurstak E (ed) Control of Virus Diseases, Sec. Edition, 179–211, Dekker: New York, p 179–211Google Scholar
  3. 3.
    Schlenker TL, Bain C, Boughman AL, Hadler SC (1992) Measles herd immunity. The association of attack rates with immunization rates in pre-school children. JAMA 267 (6): 823–826PubMedCrossRefGoogle Scholar
  4. 4.
    Preblud SR, Katz SL (1988) Measles vaccine. In: Plotkin SA, Mortimer EA (Eds) Vaccines, Saunders, Philadelphia, p 182–222Google Scholar
  5. 5.
    Taylor WR, Mambu RK, Ma-Disu M, Weinman JM (1988) Measles control efforts in urban Africa complicated by high incidence of measles in the first year of life. Am J Epidemiol 127: 788–794PubMedGoogle Scholar
  6. 6.
    Aaby P, Samb B, Simondon F, Whittle H, Sec AM, Knudsen K, Bennett J, Markowitz L, Rhoses P (1991) Child mortality after high titre measles vaccines in Senegal, the complete data set. Lancet 338:1518PubMedCrossRefGoogle Scholar
  7. 7.
    Whittle PF, Mann G, Eckles M (1988) Effect of dose and strain of vaccine on success of measles vaccination of infants aged 4–5 months. Lancet i: 963–966CrossRefGoogle Scholar
  8. 8.
    WHO/EPI (1990) Measles immunization before 9 months of age. Wkly Epidem Rec 2:8–9Google Scholar
  9. 9.
    Garenne M ,Leroy O, Beau JP ,Sene I (1991) Child mortality after high titre measles vaccine: Prospective study in Senegal. Lancet 338: 903–907PubMedCrossRefGoogle Scholar
  10. 10.
    Orenstein W (1992) World conference on poliomyelitis and measles. New Delhi, January 7–12, 1992Google Scholar
  11. 11.
    Mast EE, Berg JL, Hanrahan LP, Wassel JT, Davis JP (1990) Risk factors for measles in a previously vaccinated population and cost-effectiveness of revaccination strategies. JAMA 264(19): 2529–2533PubMedCrossRefGoogle Scholar
  12. 12.
    Centers for Disease Control (1990) Reported cases of measles by state. United States ,weeks 1417. MMWR 39:300Google Scholar
  13. 13.
    Kurstak E (1993) World conference on poliomyelitis and measles: Vaccines and immunization. Vaccine 11(1): 93–95PubMedCrossRefGoogle Scholar
  14. 14.
    Plotkin SA (1992) World conference on poliomyelitis and measles. New Delhi ,January 7–12 ,1992Google Scholar
  15. 15.
    Taylor J ,Weinberg R ,Tartaglia J, Richardson C, Alkhatib G ,Briedis D ,Appel M ,Norton E ,Paoletti E (1992) Nonreplicating viral vectors as potential vaccines: Recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology 187: 321–328PubMedCrossRefGoogle Scholar
  16. 16.
    Ajjan N ,Saliou P (1992) World conference on poliomyelitis and measles. New Delhi ,January 7–12 ,1992Google Scholar
  17. 17.
    WHO (1992) Meningitis associated with measles-mumps-rubella vaccines. Wkly Epidem Rec 67(41): 301–302Google Scholar
  18. 18.
    Patriarca PA ,Wright PF ,John TJ (1991) Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries. Rev Infect Dis 13: 926–939PubMedCrossRefGoogle Scholar
  19. 19.
    Wright PF ,Robert J ,Kim-Farley RJ ,De Quadros CA ,Robertson SE ,Scott RMcN ,Ward NA ,Henderson RH (1991) Strategies for the global eradication of poliomyelitis by the year 2000. N Eng J Med 325(25): 1774–1779CrossRefGoogle Scholar
  20. 20.
    de Quadros CA ,Andrus SK ,Olive SM ,de Macedo CG ,Henderson DA (1992) Polio eradication from the Western Hemisphere. Ann Rev Public Health 13: 239–252CrossRefGoogle Scholar
  21. 21.
    Ward NA ,Kim-Farley RJ ,Milstein JB ,Hull HF ,Tarel C ,de Quadros C (1992) Poliomyelitis eradication. The Expanded Programme on Immunization of the World Health Organization. In: Kurstak E (ed) Control of Virus Diseases ,Sec. Edition ,Dekker ,New York ,p 247–266Google Scholar
  22. 22.
    World Health Assembly (1988) Global eradication of poliomyelitis by the year 2000. Resolution WHA 41.28 ,GenevaGoogle Scholar
  23. 23.
    Kew O ,De L ,Yong CF ,Nottay B ,Pallansch M ,da Silvia E (1992) The role of virologic surveillance in the global initiative to eradicate poliomyelitis. In: Kurstak E (ed) Control of Virus Diseases ,Sec. Edition ,215-246 ,Dekker ,New York ,p 215–246Google Scholar
  24. 24.
    Faden H ,Modlin SF ,Thomas ML ,McBean AM ,Ferdon MB ,Ogra PL (1989) Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: Systemic and local immune responses. J Infect Dis 162: 1291–1297CrossRefGoogle Scholar
  25. 25.
    Marcuse EK (1989) Why Wait for DTP-E-IPV? Am J Dis Children 143: 1006–1007Google Scholar
  26. 26.
    MelnickJL (1992) Poliomyelitis: Eradication in sight. Epidemiol Infect 108: 1–18PubMedCrossRefGoogle Scholar
  27. 27.
    John TJ ,Moore R ,Gibson JJ (1992) Choice between inactivated and oral poliovirus vaccine in India. Lancet 339: 504PubMedCrossRefGoogle Scholar
  28. 28.
    Hovi T ,Huovilainen A ,Kuronen T (1986) Outbreak of paralytic poliomelitis in Finland: Widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet i: 1427–1435CrossRefGoogle Scholar
  29. 29.
    Sutter RW ,Patriarca PA ,Brogan S (1991) Outbreak of paralytic poliomyelitis in Oman: Evidence for widespread transmission among fully vaccinated children. Lancet 338:715–720PubMedCrossRefGoogle Scholar
  30. 30.
    Kohara M ,Abe S ,Komatsu T ,Tago K ,Arita M ,Nomoto A (1988) A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. J Virol 62: 2828–2835PubMedGoogle Scholar
  31. 31.
    WHO (1990) Potential use of new poliovirus vaccine. Bull World Health Organ 68: 545–548Google Scholar

Copyright information

© Springer-Verlag/Wien 1993

Authors and Affiliations

  • Edouard Kurstak

There are no affiliations available

Personalised recommendations